178 related articles for article (PubMed ID: 4214378)
1. Transport of material between brain extracellular fluid, brain cells and blood.
Fenstermacher JD; Patlak CS; Blasberg RG
Fed Proc; 1974 Sep; 33(9):2070-4. PubMed ID: 4214378
[No Abstract] [Full Text] [Related]
2. A review of blood-brain barrier transport techniques.
Smith QR
Methods Mol Med; 2003; 89():193-208. PubMed ID: 12958421
[No Abstract] [Full Text] [Related]
3. Comparative studies of capillary permeability in brain and muscle.
Crone C; Thompson AM
Acta Physiol Scand; 1973 Feb; 87(2):252-60. PubMed ID: 4718208
[No Abstract] [Full Text] [Related]
4. Transport through the ependymal linings.
Rall DP
Prog Brain Res; 1968; 29():159-72. PubMed ID: 5735304
[No Abstract] [Full Text] [Related]
5. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.
Blasberg RG; Patlak CS; Shapiro WR
Cancer Treat Rep; 1977 Jul; 61(4):633-41. PubMed ID: 406996
[No Abstract] [Full Text] [Related]
6. Comparative aspects of blood-brain exchange.
Fenstermacher JD
Fed Proc; 1980 Dec; 39(14):3201-6. PubMed ID: 7002622
[TBL] [Abstract][Full Text] [Related]
7. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
[TBL] [Abstract][Full Text] [Related]
8. Brain edema.
Fishman RA
N Engl J Med; 1975 Oct; 293(14):706-11. PubMed ID: 1160939
[No Abstract] [Full Text] [Related]
9. The pathophysiology of obstructive hydrocephalus in the monkey.
Levin VA; Milhorat TH; Fenstermacher JD; Hammock MK; Rall DD
Trans Am Neurol Assoc; 1970; 95():274-6. PubMed ID: 4998765
[No Abstract] [Full Text] [Related]
10. Transport inhibition phenomena in unilateral chemical injury of blood-brain barrier.
Steinwall O
Prog Brain Res; 1968; 29():357-65. PubMed ID: 4898333
[No Abstract] [Full Text] [Related]
11. The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier.
Levin VA; Landahl HD; Freeman-Dove MA
J Pharmacokinet Biopharm; 1976 Dec; 4(6):499-519. PubMed ID: 827606
[No Abstract] [Full Text] [Related]
12. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.
Blasberg RG; Patlak C; Fenstermacher JD
J Pharmacol Exp Ther; 1975 Oct; 195(1):73-83. PubMed ID: 810575
[TBL] [Abstract][Full Text] [Related]
13. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
14. In vitro models for the blood-brain barrier.
Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
[TBL] [Abstract][Full Text] [Related]
15. The influence of radiation on blood vessels and circulation. Chapter IX. Blood flow and permeability in the central nervous system.
Keyeux A
Curr Top Radiat Res Q; 1974 Jun; 10(1):135-50. PubMed ID: 4135299
[No Abstract] [Full Text] [Related]
16. The cerebrospinal fluid and the extracellular fluid of the brain. Introductory remarks.
Bering EA
Fed Proc; 1974 Sep; 33(9):2061-6. PubMed ID: 4418317
[No Abstract] [Full Text] [Related]
17. [Intravenous application of hylase "Dessau" on the blood-brain barrier].
Senitz D; Fischer GJ
Exp Pathol (Jena); 1972; 7(5):228-33. PubMed ID: 4660914
[No Abstract] [Full Text] [Related]
18. Lack of autoregulatory response of the cerebral circulation after osmotic opening of the blood-brain barrier in dogs.
Koźniewska E; Skolasińska K
Acta Physiol Pol; 1980; 31(4):383-9. PubMed ID: 7446151
[TBL] [Abstract][Full Text] [Related]
19. Effect of capillary efflux transport inhibition on the determination of probe recovery during in vivo microdialysis in the brain.
Sun H; Bungay PM; Elmquist WF
J Pharmacol Exp Ther; 2001 Jun; 297(3):991-1000. PubMed ID: 11356921
[TBL] [Abstract][Full Text] [Related]
20. An active transport system in the blood-brain barrier may reduce levodopa availability.
Hawkins RA; Mokashi A; Simpson IA
Exp Neurol; 2005 Sep; 195(1):267-71. PubMed ID: 15925365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
